Biopharma Analyst Chen, along with EVP & President of Manufacturing Operations, discuss the dynamics and opportunities in Incretin manufacturing on a conference call to be held on June 24 at 11:30 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Insider Trade: Lilly Endowment Sells Eli Lilly Shares Worth $172M
- Growing Demand for GLP-1 Puts Eli Lilly (NYSE:LLY) in Prime Position
- Eli Lilly works to develop more potent anti-obesity treatment, WSJ reports
- FDA grants traditional approval to Lilly’s Retevmo for thyroid cancer
- Blue Cross Blue Shield of Michigan to drop weight loss drugs, Bloomberg says